In this cross-sectional study, our results demonstrated that the ACE I/D polymorphism had no significant effect on ASCVD or cardiovascular mortality risk in non-hemodialyzed CKD patients of Javanese ethnic origin. This evidence concerns the gene ACE and chronic kidney disease.